STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M

Neuroscience Letters

Volumn 269, Issue 3, 1999, Pages 169-172

  Yanagisawa, Makoto ^a   Nakashima, Kinichi ^a   Taga, Tetsuya ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Astrocyte differentiation; Gp130; Neuroepithelial cells; Oncostatin M; STAT3

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; ONCOSTATIN M; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL MATURATION; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; MOUSE; NERVE CELL DIFFERENTIATION; NEUROEPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE-PHASE PROTEINS; ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; ECTODERM; EPITHELIAL CELLS; FETUS; GLIAL FIBRILLARY ACIDIC PROTEIN; MICE; ONCOSTATIN M; PEPTIDES; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0033575426     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00447-4     Document Type: Article

References (20)

1. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., Stahl N., Yancopoulos G.D., Greenberg M.E. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 278:1997;477-483.
2. Escary J.L., Perreau J., Duménil D., Ezine S., Brulet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature. 363:1993;361-364.
3. -) and response to cytokines using signal transducer LIFRβ Dev. Biol. 167:1995;596-608.
4. Ichihara M., Hara T., Kim H., Murate T., Miyajima A. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood. 90:1997;165-173.
5. Johe K.K., Hazel T.G., Muller T., Dugich-Djordjevic M.M., McKay R.D.G. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. 10:1996;3129-3140.
6. Kawasaki K., Gao Y.H., Yokose S., Kaji Y., Nakamura T., Suda T., Yoshida K., Taga T., Kishimoto T., Kataoka H., Yuasa T., Norimatsu H., Yamaguchi A. Osteoclasts are present in gp130-deficient mice. Endocrinology. 138:1997;4959-4965.
7. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
8. Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature. 356:1993;27-32.
9. McKay R. Stem cells in the central nervous system. Science. 276:1997;66-71.
10. Nakashima K., Taga T. gp130-stimulating cytokines: its signaling mechanism and roles in the nervous systems. Pandalai S.G. Recent Research Developments in Neurochemistry, Research Signpost. 1999;Trivandrum. in press.
11. Nakashima K., Wiese S., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Yoshida K., Kishimoto T., Sendtner M., Taga T. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J. Neurosci. 1999;. in press.
12. Nakashima K., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Kawabata M., Miyazono K., Taga T. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 284:1999;479-482.
13. Rajan P., McKay R.D.G. Multiple routes to astrocytic differentiation in the CNS. J. Neurosci. 18:1998;3620-3629.
14. Rao M.S., Symes A., Malik N., Shoyab M., Fink J.S., Landis S.C. Oncostatin M regulates VIP expression in a human neuroblastoma cell line. NeuroReport. 3:1992;865-868.
15. Stewart C.L., Kasper P., Brunet L.J., Bhatt H., Gadi I., Köntgen F., Abbondanzo S.J. Blastcyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 359:1992;76-79.
16. Taga T. gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem. 67:1996;1-10.
17. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.
18. Taga T., Kishimoto T. gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797-819.
19. Yoshida K., Taga T., Saito M., Kumanogoh A., Tanaka T., Ozono K., Nakayama M., Nakahata T., Yoshida N., Kishimoto T. Myocardial, hematological, and placental disorders caused by targeted disruption of gp130, a common signal transducer for IL-6 family of cytokines. Durum S.K., Muegge K. Contemporary Immunology: Cytokine Knockouts. 1998;259-286 Humana Press, Totowa.
20. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahara T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for IL-6-family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:1996;407-411.